United Therapeutics | UTHR - Ebit

Stock Price
473.57
Daily Change
-0.95 -0.20%
Monthly
0.04%
Yearly
32.47%
Q1 Forecast
458.74

United Therapeutics reported $389.3M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Amarin USD -1.7M 8.47M Sep/2025
Ardelyx USD 7.12M 19.62M Sep/2025
Baxter International USD -214.2M 415.4M Dec/2025
Bayer EUR -399M 363M Sep/2025
BioCryst Pharmaceuticals USD -4.51M 12.2M Dec/2024
Biogen USD 659.6M 157M Sep/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Esperion Therapeutics USD -16.03M 11.51M Sep/2024
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Insmed USD -249.71M 11.64M Dec/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Lexicon Pharmaceuticals USD -49.63M 5.39M Sep/2023
Moderna USD -857M 597M Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Pfizer USD 4.65B 71M Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025